Kinetics of Diol and Hydroxybenzo[a]pyrene Metabolites in Relation to DNA Adduct Formation and Gene Expression in Rats

REFERENCES

• Aylward, L., Hays, S., Smolders, R., Koch, H., Cocker, J., Jones, K., Warren, N., Levy, L., and Bevan, R. 2014. Sources of variability in biomarker concentrations. J. Toxicol. Environ. Health B 17: 45–61.
   PubMed Web of Science ®Google Scholar
• Baird, W., Hooven, L., and Mahadevan, B. 2005. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ. Mol. Mutagen. 45: 106–114.
   PubMed Web of Science ®Google Scholar
• Barbeau, D., Persoons, R., Marques, M., Herve, C., Laffitte-Rigaud, G., and Maitre, A. 2014. Relevance of urinary 3-hydroxybenzo(a)pyrene and 1-hydroxypyrene to assess exposure to carcinogenic polycyclic aromatic hydrocarbon mixtures in metallurgy workers. Ann. Occup. Hyg. 58: 579–590.
   PubMed Web of Science ®Google Scholar
• Barbeau, D., Maitre, A., and Marques, M. 2011. Highly sensitive routine method for urinary 3-hydroxybenzo[a]pyrene quantitation using liquid chromatography-fluorescence detection and automated off-line solid phase extraction. Analyst 136: 1183–1191.
   PubMed Web of Science ®Google Scholar
• Barbeau, D., Marques, M., and Maître, A. 2009. The 3-hydroxybenzo(a)pyrene as a new biomarker of exposure carcinogenic polycyclic aromatic hydrocarbons. 46th Congress of European Societies of Toxicology EUROTOX, Toxicol. Lett., Dresden, Germany, S160.
   Google Scholar
• Bartosiewicz, M., Penn, S., and Buckpitt, A. 2001. Applications of gene arrays in environmental toxicology: Fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ. Health Perspect. 109: 71–74.
   PubMed Web of Science ®Google Scholar
• Bloom, D. A., and Jaiswal, A. K. 2003. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H: quinoneoxidoreductase-1 gene expression. J. Biol. Chem. 278: 44675–44682.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., Dodd, C., and Viau, C. 1994. Improved procedure for the high-performance liquid chromatographic determination of monohydroxylated PAH metabolites in urine. J. Anal. Toxicol. 18: 261–264.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., Krishnan, K., and Viau, C. 1998. Kinetics of tissue distribution and elimination of pyrene and 1-hydroxypyrene following intravenous administration of [14C]pyrene in rats. Toxicol. Sci. 46: 11–20.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., and Viau, C. 1996. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites. Toxicol. Appl. Pharmacol. 139: 301–309.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., and Viau, C. 1997. Urinary excretion of benzo[a]pyrene metabolites following intravenous, oral, and cutaneous benzo[a]pyrene administration. Can. J. Physiol. Pharmacol. 75: 185–192.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., and Viau, C. 1999. Urinary 1-hydroxypyrene as a biomarker of exposure to polycyclic aromatic hydrocarbons: Biological monitoring strategies and methodology for determining biological exposure indices for various work environments. Biomarkers 4: 159–187.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., Viau, C., Marie, C., and Maitre, A. 2010. Apport de la toxicocinétique dans le suivi biologique des expositions aux hydrocarbures aromatiques polycicliques. Arch. Maladies Professionnelles 71: 520–522.
   Web of Science ®Google Scholar
• Burczynski, M. E., and Penning, T. M. 2000. Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor. Cancer Res. 60: 908–915.
   PubMed Web of Science ®Google Scholar
• Castorena-Torres, F., Bermudez de Leon, M., Cisneros, B., Zapata-Perez, O., Salinas, J. E., and Albores, A. 2008. Changes in gene expression induced by polycyclic aromatic hydrocarbons in the human cell lines HepG2 and A549. Toxicol. In Vitro 22: 411–421.
   PubMed Web of Science ®Google Scholar
• Cavalieri, E. L., and Rogan, E. G. 1995. Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 25: 677–688.
   PubMed Web of Science ®Google Scholar
• Chipman, J. K., Hirom, P. C., Frost, G. S., and Millburn, P. 1981. The biliary excretion and enterohepatic circulation of benzo(a)pyrene and its metabolites in the rat. Biochem. Pharmacol. 30: 937–944.
   PubMed Web of Science ®Google Scholar
• Devanesan, P. D., RamaKrishna, N. V., Todorovic, R., Rogan, E. G., Cavalieri, E. L., Jeong, H., Jankowiak, R., and Small, G. J. 1992. Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro. Chem. Res. Toxicol. 5: 302–309.
   PubMed Web of Science ®Google Scholar
• Divi, R. L., Beland, F. A., Fu, P. P., Von Tungeln, L. S., Schoket, B., Camara, J. E., Ghei, M., Rothman, N., Sinha, R., and Poirier, M. C. 2002. Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: Validation by comparison with other methods, and use in human biomonitoring. Carcinogenesis 23: 2043–2049.
   PubMed Web of Science ®Google Scholar
• Elmhirst, T. R., Chipman, J. K., Ribeiro, O., Hirom, P. C., and Millburn, P. 1985. Metabolism and enterohepatic circulation of benzo(a)pyrene-4,5-epoxide in the rat. Xenobiotica 15: 899–906.
   PubMed Web of Science ®Google Scholar
• Foth, H., Kahl, R. and Kahl, G. F. 1988. Pharmacokinetics of low doses of benzo[a]pyrene in the rat. Food Chem. Toxicol. 26: 45–51.
   PubMed Web of Science ®Google Scholar
• Gendre, C., Lafontaine, M., Delsaut, P., and Simon, P. 2004. Exposure to polycyclic aromatic hydrocarbons and excretion of urinary 3-hydroxybenzo(a)pyrene: Assessment of an appropriate sampling time. Polycyclic Aromatic Compounds 24: 433–439.
   Web of Science ®Google Scholar
• Godschalk, R. W., Moonen, E. J., Schilderman, P. A., Broekmans, W. M., Kleinjans, J. C., and Van Schooten, F. J. 2000. Exposure-route-dependent DNA adduct formation by polycyclic aromatic hydrocarbons. Carcinogenesis 21: 87–92.
   PubMed Web of Science ®Google Scholar
• Harrigan, J. A., McGarrigle, B. P., Sutter, T. R., and Olson, J. R. 2006. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene. Toxicol. In Vitro 20: 426–438.
   PubMed Web of Science ®Google Scholar
• Hartman, A. R., and Ford, J. M. 2002. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat. Genet. 32: 180–184.
   PubMed Web of Science ®Google Scholar
• Hecht, S. S., Carmella, S. G., Villalta, P. W., and Hochalter, J. B. 2010. Analysis of phenanthrene and benzo[a]pyrene tetraol enantiomers in human urine: Relevance to the bay region diol epoxide hypothesis of benzo[a]pyrene carcinogenesis and to biomarker studies. Chem. Res. Toxicol. 23: 900–908.
   PubMed Web of Science ®Google Scholar
• Heredia-Ortiz, R., and Bouchard, M. 2013. Understanding the linked kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker of exposure using physiologically-based pharmacokinetic modelling in rats. J. Pharmacokinet. Pharmacodyn. 40: 669–682.
   PubMed Web of Science ®Google Scholar
• Heredia-Ortiz, R., Bouchard, M., Marie-Desvergne, C., Viau, C., and Maitre, A. 2011. Modeling of the internal kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker from rat data. Toxicol. Sci. 122: 275–287.
   PubMed Web of Science ®Google Scholar
• Hockley, S. L., Arlt, V. M., Brewer, D., Giddings, I., and Phillips, D. H. 2006. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2. BMC Genomics 7: 260.
   PubMed Web of Science ®Google Scholar
• Hockley, S. L., Arlt, V. M., Brewer, D., Te Poele, R., Workman, P., Giddings, I., and Phillips, D. H. 2007. AHR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines. Chem. Res. Toxicol. 20: 1797–1810.
   PubMed Web of Science ®Google Scholar
• IARC. 2010. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monogr. Eval. Carcinog. Risks Hum. 92: 1–853.
   PubMedGoogle Scholar
• Jongeneelen, F. J., Anzion, R. B., Leijdekkers, C. M., Bos, R. P., and Henderson, P. T. 1985. 1-Hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product. Int. Arch. Occup. Environ. Health 57: 47–55.
   PubMed Web of Science ®Google Scholar
• Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M. A., Strickland, P. T., and Sutter, T. R. 1998. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19: 1847–1853.
   PubMed Web of Science ®Google Scholar
• Koreeda, M., Moore, P. D., Wislocki, P. G., Levin, W., Yagi, H., and Jerina, D. M. 1978. Binding of benzo[a]pyrene 7,8-diol-9,10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity. Science 199: 778–781.
   PubMed Web of Science ®Google Scholar
• Kwack, S. J., Kim, D. Y., Kim, Y. J., Roh, T. H., Choi, S. M., Lim, D. S., Shin, H. S., Kim, H. S., and Lee, B. M. 2014. Potential application of benzo(a)pyrene-associated adducts (globin or lipid) as blood biomarkers for target organ exposure and human risk assessment. J. Toxicol. Environ. Health A 77: 1491–1501.
   PubMed Web of Science ®Google Scholar
• Lemaire, P., Sturve, J., Forlin, L., and Livingstone, D. R. 1996. Studies on aromatic hydrocarbon quinone metabolism and DT-diaphorase function in liver of fish species. Mar. Environ. Res. 42: 317–321.
   Web of Science ®Google Scholar
• Leroyer, A., Jeandel, F., Maitre, A., Howsam, M., Deplanque, D., Mazzuca, M., and Nisse, C. 2010. 1-Hydroxypyrene and 3-hydroxybenzo[a]pyrene as biomarkers of exposure to PAH in various environmental exposure situations. Sci. Total Environ. 408: 1166–1173.
   PubMed Web of Science ®Google Scholar
• Likhachev, A. J., Beniashvili, D., Bykov, V. J., Dikun, P. P., Tyndyk, M. L., Savochkina, I. V., Yermilov, V. B., and Zabezhinski, M. A. 1992. Biomarkers for individual susceptibility to carcinogenic agents: Excretion and carcinogenic risk of benzo[a]pyrene metabolites. Environ. Health Perspect. 98: 211–214.
   PubMed Web of Science ®Google Scholar
• Lu, X., Shao, J., Li, H., and Yu, Y. 2009. Early whole-genome transcriptional response induced by benzo[a]pyrene diol epoxide in a normal human cell line. Genomics 93: 332–342.
   PubMed Web of Science ®Google Scholar
• Lu, X., Shao, J., Li, H., and Yu, Y. 2010. Temporal gene expression changes induced by a low concentration of benzo[a]pyrene diol epoxide in a normal human cell line. Mutat. Res. 684: 74–80.
   PubMed Web of Science ®Google Scholar
• Marie-Desvergne, C., Maitre, A., Bouchard, M., Ravanat, J.L. and Viau, C. 2010. Evaluation of DNA adducts, DNA and RNA oxidative lesions, and 3-hydroxybenzo(a)pyrene as biomarkers of DNA damage in lung following intravenous injection of the parent compound in rats. Chem. Res. Toxicol. 23: 1207–1214.
   PubMed Web of Science ®Google Scholar
• Marie, C., Bouchard, M., Heredia-Ortiz, R., Viau, C. and Maître, A. 2010. A toxicokinetic study to elucidate 3-hydroxybenzo(a)pyrene atypical urinary excretion profile following intravenous injection of benzo(a)pyrene in rats. J. Appl. 30: 402–410.
   Web of Science ®Google Scholar
• Moir, D., Viau, A., Chu, I., Withey, J., and McMullen, E. 1998. Pharmacokinetics of benzo[a]pyrene in the rat. J. Toxicol. Environ. Health A 53: 507–530.
   PubMed Web of Science ®Google Scholar
• Molliere, M., Foth, H., Kahl, R. and Kahl, G. F. 1987. Comparison of benzo(a)pyrene metabolism in isolated perfused rat lung and liver. Arch. Toxicol. 60: 270–277.
   PubMed Web of Science ®Google Scholar
• Moreau, M., Bouchard, M., and Ayotte, P. 2015. Effect of benzo(a)pyrene exposure dose on levels of exposure biomarkers, DNA adducts and gene expression. J. Toxicol. Environ. Health A 79: 1–19.
   Google Scholar
• Nguyen, P. M., Park, M. S., Chow, M., Chang, J. H., Wrischnik, L., and Chan, W. K. 2010. Benzo[a]pyrene increases the Nrf2 content by downregulating the Keap1 message. Toxicol. Sci. 116: 549–561.
   PubMed Web of Science ®Google Scholar
• Nguyen, T., Nioi, P., and Pickett, C. B. 2009. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284: 13291–13295.
   PubMed Web of Science ®Google Scholar
• Park, J. H., Mangal, D., Frey, A. J., Harvey, R. G., Blair, I. A., and Penning, T. M. 2009. Aryl hydrocarbon receptor facilitates DNA strand breaks and 8-oxo-2’-deoxyguanosine formation by the aldo-keto reductase product benzo[a]pyrene-7,8-dione. J. Biol. Chem. 284: 29725–29734.
   PubMed Web of Science ®Google Scholar
• Park, S. Y., Lee, S. M., Ye, S. K., Yoon, S. H., Chung, M. H., and Choi, J. 2006. Benzo[a]pyrene-induced DNA damage and p53 modulation in human hepatoma HepG2 cells for the identification of potential biomarkers for PAH monitoring and risk assessment. Toxicol. Lett. 167: 27–33.
   PubMed Web of Science ®Google Scholar
• Pitot, H. C. 1993. The molecular biology of carcinogenesis. Cancer 72: 962–970.
   PubMed Web of Science ®Google Scholar
• Qin, G., and Meng, Z. 2006. The expressions of protooncogenes and CYP1A in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene. Regul. Toxicol. Pharmacol. 45: 36–43.
   PubMed Web of Science ®Google Scholar
• Qin, G., and Meng, Z. 2010. Expression of oncogenes and tumor suppressor genes in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene. Inhal. Toxicol. 22: 322–329.
   PubMed Web of Science ®Google Scholar
• Qu, S. X., and Stacey, N. H. 1996. Formation and persistence of DNA adducts in different target tissues of rats after multiple administration of benzo[a]pyrene. Carcinogenesis 17: 53–59.
   PubMed Web of Science ®Google Scholar
• Ramesh, A., Inyang, F., Hood, D. B., Archibong, A. E., Knuckles, M. E., and Nyanda, A. M. 2001. Metabolism, bioavailability, and toxicokinetics of benzo(alpha)pyrene in F-344 rats following oral administration. Exp. Toxicol. Pathol. 53: 275–290.
   PubMed Web of Science ®Google Scholar
• Ross, J., Nelson, G., Kligerman, A., Erexson, G., Bryant, M., Earley, K., Gupta, R., and Nesnow, S. 1990. Formation and persistence of novel benzo(a)pyrene adducts in rat lung, liver, and peripheral blood lymphocyte DNA. Cancer Res. 50: 5088–5094.
   PubMed Web of Science ®Google Scholar
• Ross, J. A., Nelson, G. B., Wilson, K. H., Rabinowitz, J. R., Galati, A., Stoner, G. D., Nesnow, S., and Mass, M. J. 1995. Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. Cancer Res. 55: 1039–1044.
   PubMed Web of Science ®Google Scholar
• Roth, R. A., and Vinegar, A. 1990. Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo(a)pyrene disposition. Pharmacol. Ther. 48: 143–155.
   PubMed Web of Science ®Google Scholar
• Sadikovic, B., and Rodenhiser, D. I. 2006. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells. Toxicol. Appl. Pharmacol. 216: 458–468.
   PubMed Web of Science ®Google Scholar
• Schanzer, W., Geyer, H., and Donike, M. 1991. Metabolism of metandienone in man: Identification and synthesis of conjugated excreted urinary metabolites, determination of excretion rates and gas chromatographic-mass spectrometric identification of bis-hydroxylated metabolites. J. Steroid Biochem. Mol. Biol. 38: 441–464.
   PubMed Web of Science ®Google Scholar
• Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., and Livingston, D. M. 1997. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425–435.
   PubMed Web of Science ®Google Scholar
• Shackelford, R. E., Kaufmann, W. K., and Paules, R. S. 1999. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ. Health Perspect. 107(suppl. 1): 5–24.
   PubMed Web of Science ®Google Scholar
• Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., and Ishikawa, T. 2000. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad Sci. USA 97: 779–782.
   PubMed Web of Science ®Google Scholar
• Shou, M., Harvey, R. G., and Penning, T. M. 1993. Reactivity of benzo[a]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis 14: 475–482.
   PubMed Web of Science ®Google Scholar
• Tekpli, X., Rivedal, E., Gorria, M., Landvik, N. E., Rissel, M., Dimanche-Boitrel, M. T., Baffet, G., Holme, J. A., and Lagadic-Gossmann, D. 2010. The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis. Toxicol. Appl. Pharmacol. 242: 231–240.
   PubMed Web of Science ®Google Scholar
• Uno, S., Dalton, T. P., Derkenne, S., Curran, C. P., Miller, M. L., Shertzer, H. G., and Nebert, D. W. 2004. Oral exposure to benzo[a]pyrene in the mouse: Detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol. Pharmacol. 65: 1225–1237.
   PubMed Web of Science ®Google Scholar
• Uno, S., Dalton, T. P., Dragin, N., Curran, C. P., Derkenne, S., Miller, M. L., Shertzer, H. G., Gonzalez, F. J., and Nebert, D. W. 2006. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol. Pharmacol. 69: 1103–1114.
   PubMed Web of Science ®Google Scholar
• Uppstad, H., Ovrebo, S., Haugen, A., and Mollerup, S. 2010. Importance of CYP1A1 and CYP1B1 in bioactivation of benzo[a]pyrene in human lung cell lines. Toxicol. Lett. 192: 221–228.
   PubMed Web of Science ®Google Scholar
• van de Wiel, J. A., Fijneman, P. H., Duijf, C. M., Anzion, R. B., Theuws, J. L., and Bos, R. P. 1993. Excretion of benzo[a]pyrene and metabolites in urine and feces of rats: Influence of route of administration, sex and long-term ethanol treatment. Toxicology 80: 103–115.
   PubMed Web of Science ®Google Scholar
• van Delft, J. H., Mathijs, K., Staal, Y. C., van Herwijnen, M. H., Brauers, K. J., Boorsma, A., and Kleinjans, J. C. 2010. Time series analysis of benzo[a]pyrene-induced transcriptome changes suggests that a network of transcription factors regulates the effects on functional gene sets. Toxicol. Sci. 117: 381–392.
   PubMed Web of Science ®Google Scholar
• van Schooten, F. J., Moonen, E. J., van der Wal, L., Levels, P., and Kleinjans, J. C. 1997. Determination of polycyclic aromatic hydrocarbons (PAH) and their metabolites in blood, feces, and urine of rats orally exposed to PAH contaminated soils. Arch. Environ. Contam. Toxicol. 33: 317–322.
   PubMed Web of Science ®Google Scholar
• Venugopal, R., and Jaiswal, A. K. 1996. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H: quinoneoxidoreductase1 gene. Proc. Natl. Acad. Sci. USA 93: 14960–14965.
   PubMed Web of Science ®Google Scholar
• Vondracek, J., Krcmar, P., Prochazkova, J., Trilecova, L., Gavelova, M., Skalova, L., Szotakova, B., Buncek, M., Radilova, H., Kozubik, A., and Machala, M. 2009. The role of aryl hydrocarbon receptor in regulation of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons in a model of rat liver progenitor cells. Chem. Biol. Interact. 180: 226–237.
   PubMed Web of Science ®Google Scholar
• Wang, J. J., Frazer, D. G., Law, B., and Lewis, D. M. 2003a. Identification and quantification of urinary benzo[a]pyrene and its metabolites from asphalt fume exposed mice by microflow LC coupled to hybrid quadrupole time-of-flight mass spectrometry. Analyst 128: 864–870.
   PubMed Web of Science ®Google Scholar
• Wang, J. J., Frazer, D. G., Stone, S., Goldsmith, T., Law, B., Moseley, A., Simpson, J., Afshari, A., and Lewis, D. M. 2003b. Urinary benzo[a]pyrene and its metabolites as molecular biomarkers of asphalt fume exposure characterized by microflow LC coupled to hybrid quadrupole time-of-flight mass spectrometry. Anal. Chem. 75: 5953–5960.
   PubMed Web of Science ®Google Scholar
• Wei, Q., Gu, J., Cheng, L., Bondy, M. L., Jiang, H., Hong, W. K., and Spitz, M. R. 1996. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res. 56: 3975–3979.
   PubMed Web of Science ®Google Scholar
• Won Lee, H. S. S., Hong, J. E., Pyo, H., and Kim, Y. 2003. Studies on the analysis of benzo(a)pyrene and its metabolites in biological samples by using high performance liquid chromatograpy/fluorescence detection and gas chromatography/mass spectrometry. Bull. Korean Chem. Soc. 24: 559–565.
   Web of Science ®Google Scholar
• Wu, J., Ramesh, A., Nayyar, T., and Hood, D. B. 2003. Assessment of metabolites and AhR and CYP1A1 mRNA expression subsequent to prenatal exposure to inhaled benzo(a)pyrene. Int. J. Dev. Neurosci. 21: 333–346.
   PubMed Web of Science ®Google Scholar
• Yang, S. K., Roller, P. P., and Gelboin, H. V. 1977. Enzymatic mechanism of benzo[a]pyrene conversion to phenols and diols and an improved high-pressure liquid chromatographic separation of benzo[a]pyrene derivatives. Biochemistry 16: 3680–3687.
   PubMed Web of Science ®Google Scholar
• Yauk, C. L., Jackson, K., Malowany, M., and Williams, A. 2010. Lack of change in microRNA expression in adult mouse liver following treatment with benzo(a)pyrene despite robust mRNA transcriptional response. Mutat. Res. 722: 131–139.
   PubMed Web of Science ®Google Scholar
• Zhao, W., and Ramos, K. S. 1998. Modulation of hepatocyte gene expression by the carcinogen benzo[a]pyrene. Toxicol. In Vitro 12: 395–402.
   PubMed Web of Science ®Google Scholar